-
DST-SERB supports study to identify structure-based potential antivirals against COVID 19
expresspharma
May 28, 2020
The investigators have already performed the in silico work by high-throughput virtual screening approach to examine the binding affinity of FDA approved drugs targeting the viral protease Mpro.
-
Algernon submits IND application with FDA for possible Covid-19 treatment
pharmaceutical-business-review
May 27, 2020
Algernon Pharmaceuticals has completed the submission of an investigational new drug (IND) application to the US Food and Drug Administration (FDA) to assess the Ifenprodil in the phase 2b/3 clinical study to treat Covid-19 patients.
-
Study reveals distinct features of deceased COVID-19 patients’ lungs
expresspharma
May 27, 2020
The researchers speculate that the greater degree of clot formation and blood vessel generation in COVID-19 patients may have contributed to the unique lung features.
-
Dalmia Group to start clinical trial for Astha 15
expresspharma
May 27, 2020
The Ministry of AYUSH has given Dalmia Group the green signal to commence clinical trials for its Ayurvedic composition Astha 15 for the treatment of COVID-19, informed the company in a statement.
-
Pathnostics Launches COVID-19 PCR Laboratory Test Designed to Detect Acute Infection
americanpharmaceuticalreview
May 27, 2020
Pathnostics has launched a COVID-19 polymerase chain reaction (PCR) laboratory test designed to support U.S. health care workers.
-
ADMA Biologics Begins Collection of COVID-19 Plasma from Recovered Patients
americanpharmaceuticalreview
May 27, 2020
ADMA Biologics has commenced the collection of convalescent plasma through its wholly-owned subsidiary, ADMA BioCenters Georgia, from individuals who have recovered from COVID-19.
-
Merck joins race to develop Covid-19 vaccines and drugs
pharmaceutical-technology
May 27, 2020
Merck (MSD) has joined the race to develop vaccines and treatments against Covid-19 with separate agreements with Themis, IAVI and Ridgeback Biotherapeutics.
-
‘At home’ COVID-19 antibody tests: expert opinions and manufacturer warnings
europeanpharmaceuticalreview
May 27, 2020
Abbott has revealed it’s SARS-CoV-2 antibody test was not designed for at home use despite companies selling them for this purpose. Also, what do experts think about these tests?
-
Glenmark Begins Phase III Trial of Anti-Viral Combo in COVID-19
contractpharma
May 27, 2020
To test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19 treatment.
-
Montefiore, Einstein Test New Drug Combo to Conquer COVID-19
contractpharma
May 27, 2020
Researchers hope giving remdesivir along with a powerful anti-inflammatory could be the key to treating the most severe COVID-19 cases.